1. Field of Invention
The present invention relates to medical devices. More particularly, the invention relates to occluding devices and methods of occluding fluid flow through a body vessel.
2. Background
Embolization coils have been used as a primary occluding device for treatment of various arteriovenous malformations (AVM) and varicoceles, as well as for many other arteriovenous abnormalities in the body. Occluding devices are also used to repair abnormal shunts between arteries and veins, prevent or reduce blood flow to tumors, stop hemorrhaging as a result of trauma, and stabilize aneurysms to prevent rupture. Embolization coils, for example pushable fibered coils, may be configured in a variety of sizes with varying diameters and may be made of several different materials including stainless steel and platinum. Occlusion devices may vary for differing purposes, e.g., to hold the device in place within a cavity or vessel and to pack the device within the vessel for enhanced occlusion.
Although current coils are adequate, such coils may be improved for more effective occlusion of fluid flow through a lumen of a body vessel. Many medical procedures for occluding blood flow through an artery or vein require a number of coils, since a single coil or two may not be sufficient to effectively occlude blood flow through a lumen of an artery or vein. For example, a coil having greater stiffness or rigidity may be introduced into a blood vessel and various coils of decreasing stiffness or rigidity may follow behind the stiffer coil. This procedure may involve an undesirable amount of additional time and increased costs associated with manufacturing and deploying a number of different coils.
The present invention provides an improved occluding device and an improved method of delivering the device for occluding fluid flow through a lumen of a body vessel.
In one form, the occluding device includes an embolization coil with a distal end and a proximal end with an opening and a suture or an attacher that is threaded through the opening at the proximal end of the embolization coil.
In another form, the occluding device includes an embolization coil with a distal end and a proximal end and a suture or an attacher that is tied as a slip-knot around the proximal end of the embolization coil.
Other forms of the invention includes methods of using the aforementioned occlusion devices to occlude fluid flow in a body vessel.
Further features and advantages will become apparent from the following description and from the claims.
a is a partial side view of a coiled wire in accordance with one embodiment of the present invention;
b is a partial side perspective view of an occluding device in accordance with the embodiment of
a is a close up view of a suture delivery arrangement for an occluding device in accordance with yet another embodiment of the present invention;
b is a close up view of a slip knot for the suture delivery arrangement of
a is an exploded view of an embolization kit in accordance with an embodiment of an occluding device of the present invention;
b is a side view of an embolization kit in accordance with an embodiment of the present invention;
The following provides a detailed description of currently preferred embodiments of the present invention. The description is not intended to limit the invention in any manner, but rather serves to enable those skilled in the art to make and use the invention.
The present invention generally provides an occluding device, and delivery for such a device, used for transcatheter embolization to provide an improved occlusion of fluid flow through the vessel. The occluding device is an embolization coil preferably used to occlude fluid flow through a lumen of a body vessel such as for an occlusion of an arteriovenous malformation (AVM). The occluding device include a primary coil formed into a helical shape and further defines a secondary coil. To further facilitate occlusion of fluid flow the occluding device may include fibers attached between loops of the primary coil and extending therefrom.
The occluding device also may be employed for treatment of renal arteriovenous malfunction (AVM), pulmonary AVM, vascular tumors, low-flow fistulas, trauma related hemorrhages, and visceral vasculature defects including varicoceles, aneurysms, and selected telangiectasias. For example, treatment of visceral vasculature defects may include but are not limited to embolotherapy on gastroduogenal hemorrhages, hepatic aneurysms, celiac aneurysms, internal iliac aneurysms, and internal spermatic varicoceles.
Referring to
As illustrated in
Typically, the wire 30 is wound about the longitudinal axis 35 into a longitudinally extending secondary coil 28 having an inner lumen 31 through which a wire 20 (
In some implementations, the wire 20 is curled or coiled about a longitudinal axis 27 into a primary coil 18 having a primary shape defined by a plurality of turns or loops 26 wound about the longitudinal axis 26 of the primary coil 18 and axially spaced apart by a predetermined distance. The plurality of loops 26 defines a cross-sectional area formed axially along the primary coil 18. The wire 20 may be coiled into the primary coil 18 by any apparatus known in the art, such as a roller deflecting apparatus, a mandrel apparatus, or any other suitable means. For example, the wire 20 may be wound about a mandrel and heat set to form its spiral shape. Alternatively, the wire 20 may be wound about a longitudinally tapered mandrel and heat set to form a conically helically shaped coil.
In this embodiment, the secondary coil 28 has a generally linear primary shape and includes a plurality of tightly spaced turns 36 with minimal, if any spacing 37 therebetween. The generally linear primary shape is defined by a generally constant primary diameter dp2. The wire 30 is wound into the secondary coil 28 by any apparatus known in the art, such as a roller deflecting apparatus, a mandrel apparatus, or any other suitable means. For example, the wire 30 may be wrapped around a mandrel and heat set to form its primary shape.
As illustrated in
In this embodiment, the central axis 35 of the secondary coil 28 is aligned with the central axis 25 of the coiled wire 20. With the distal end 34 of the secondary coil 28 adjacent the proximal end 22 of the coiled wire 20, the secondary coil 28 slides over the coiled wire 20 until the distal end 34 of the secondary coil 28 meets the distal end 24 of the coiled wire 20. In this arrangement, the secondary coil 28 conforms to the shape of the coiled wire 20 as the overlying secondary coil 28 moves along the plurality of loops 26 of the coiled wire 20, coiling about the longitudinal axis 27, and thus forming the secondary shape of the secondary coil 28.
In another arrangement, the coiled wire 20 may be straightened before being received within the lumen 31 of the linear longitudinally extending secondary coil 28. In this arrangement, the central axis 35 of the secondary coil 28 is aligned with the central axis 25 of the wire 20. With the distal end 34 of the secondary coil 28 adjacent the proximal end 22 of the wire 20, the secondary coil 28 slides over the straightened wire 20 until the distal end 34 of the secondary coil 28 meets the distal end 24 of the tapered wire 20. Thereafter, the wire 20 within the secondary coil 28 returns to its coiled configuration (i.e., the primary coil 18) causing the secondary coil 28 to take the shape of the primary coil 18, both the primary coil 18 and the secondary coil 28 coiling about the longitudinal axis 27, thus forming the secondary shape of the secondary coil 28.
Thus, the coiled wire 20 (i.e., primary coil 18) provides the secondary coil 28 with its secondary shape defined by the plurality of axially spaced loops 26. Thus, the wire 20 serves as an inner mandrel within the secondary coil 28. If the wire 20 is tapered it further provides the secondary coil 28 with a gradually decreasing stiffness from the distal end 34 to the proximal end 32, resulting in a variable strength occluding device.
Further details of the aforementioned occluding devices are described in U.S. application Ser. No. 12/171,900, filed Jul. 11, 2008, the entire contents of which are incorporated herein by reference.
The secondary shape of the secondary coil 28 is shaped by the primary shape of the primary coil 18, and thus the secondary diameter ds corresponds with the primary diameter of the primary coil 18 and may be generally constant or varied. Alternatively, the secondary shape may be non-linear and include a plurality of radially expanding loops 26 (i.e., a radially increasing secondary diameter ds) forming a conically helically shaped coil, an example of which is illustrated in
As shown in
The fibers 238 may be attached to the wire 30 before or after the wire 30 is coiled into the secondary coil 28. In a preferred embodiment, the fibers 238 include strands comprising a synthetic polymer such as polyester textile fiber, e.g., DACRON™. As desired, the strands may be positioned between adjacent loops, alternating loops, alternating double loops, or any desired configuration.
Preferably, the wires 20, 30 making up the primary 18 and secondary coils 28 are made of any suitable material that will result in the device 10 capable of being percutaneously inserted and deployed within a body cavity. Examples of preferred materials include metallic materials, such as stainless steel, platinum, iron, iridium, palladium, tungsten, gold, rhodium, rhenium, and the like, as well as alloys of these metals. Other suitable materials include superelastic materials, a cobalt-chromium-nickel-molybdenum-iron alloy, a cobalt chrome-alloy, stress relieved metal, nickel-based superalloys, such as Inconel, or any magnetic resonance imaging (MRI) compatible material, including materials such as a polypropylene, nitinol, titanium, copper, or other metals that do not disturb MRI images adversely. The wires 20, 30 may also be made of radiopaque material, including tantalum, barium sulfate, tungsten carbide, bismuth oxide, barium sulfate, and cobalt alloys.
Further, the wires 20, 30 making up the primary 18 and secondary coils 28 may be fabricated from shape memory materials or alloys, such as superelastic nickel-titanium alloys. An example of a suitable superelastic nickel-titanium alloy is Nitinol, which can “remember” and recover a previous shape. Nitinol undergoes a reversible phase transformation between a martensitic phase and an austenitic phase that allows it to “remember” and return to a previous shape or configuration. For example, compressive strain imparted to the coils 18, 28 in the martensitic phase to achieve a low-profile delivery configuration may be substantially recovered during a reverse phase transformation to austenite, such that the coils 18, 28 expand to a “remembered” (e.g., deployed) configuration at a treatment site in a vessel. Typically, recoverable strains of about 8-10% may be obtained from superelastic nickel-titanium alloys. The forward and reverse phase transformations may be driven by a change in stress (superelastic effect) and/or temperature (shape memory effect).
Slightly nickel-rich Nitinol alloys including, for example, about 51% Ni and about 49% Ti are known to be useful for medical devices which are superelastic at body temperature. In particular, alloys including 50.6-50.8% Ni and 49.2-49.4% Ti are considered to be medical grade Nitinol alloys and are suitable for the present coils 18, 28. The nickel-titanium alloy may include one or more additional alloying elements.
In a preferred embodiment, the wire 20 (i.e., primary coil 18) is made of nitinol or stainless steel and the wire 30 (i.e., secondary coil 28) is made of palladium. A primary coil 18 made of nitinol, for example, may provide many clinical advantages. After the nitinol tapered wire 20 is initially curled or coiled into the primary coil 18, it is effectively straightened-out in order to thread or slide the secondary coil 28 over it. Nitinol's super-elastic properties allow the tapered wire 20 to recover from the straightening strain and later return to its coiled primary shape.
Alternatively, the nitinol tapered wire 20 may be curled or coiled into the primary coil 18 and heat-set such that after it is effectively straightened for sliding the secondary coil 28 over it, the device 10 (i.e., the tapered wire 20 within the secondary coil 28) may be heated to a predetermined activating temperature to induce the shape-memory property of the nitinol tapered wire 20 and cause it to return to the coiled configuration (i.e., primary shape) of the primary coil 18, thus causing the secondary coil 28 to take on the primary shape of the primary coil 18.
In this embodiment, the device 10 may be stored in the straightened configuration for delivery to the interventionalist. As the device 10 is introduced into the body, body heat activates the shape-memory property of the nitinol tapered wire 20 within the secondary coil 28 and causes the tapered wire 20 to return to the primary shape of the primary coil 18, and thus causes the secondary coil 28 to take on the primary shape of the primary coil 18. The nitinol tapered wire 20 thus provides the secondary coil 28 with its secondary shape and variable stiffness due to the tapered diameter of the wire 20, therefore serving as an inner mandrel within the secondary coil 28.
In a particular embodiment, the proximal 32 and/or the distal end 34, of the secondary coil 28 includes a cap that may be soldered or welded to present to the coil 28 to provide a rounded or smooth surface, which will not catch on the interior surface of the guiding catheter or provide a source of trauma for the vasculature.
For example, as shown in
As such, as shown in
Therefore, the physician can push the device 10 out the distal end of the catheter 314 with a wire and, if the device 10 is not in the desired position, then pull on the suture 254, and therefore the device 10, to reposition the device. During this process the device may potentially be pulled back into the catheter one or several times. When the device 10 is ready to be released, the physician, in step 506, pulls on one of the extensions to remove the suture 254 from the device 10. The suture 254 may be biodegradable so that it can be left in the patient's body. Additionally, the suture 254 may itself be thrombogenic in the vascular system to enhance the embolization.
In another form, as shown in
In yet another form, as shown in
Referring know to
Turning now to
In this embodiment, the kit 310 further includes a polytetrafluoroethylene (PTFE) guide catheter or sheath 324 for percutaneously introducing the inner catheter 314 in a body vessel 14. Of course, any other suitable material may be used without falling beyond the scope or spirit of the present invention. The guide catheter 324 may have a size of about 4-French to 8-French and allows the inner catheter 314 to be inserted therethrough to a desired location in the body cavity. The guide catheter 324 receives the inner catheter 314 and provides stability of the inner catheter 314 at a desired location of the body cavity. For example, the guide catheter 324 may stay stationary within a common visceral artery, e.g., a common hepatic artery, and add stability to the inner catheter 314 as the inner catheter is advanced through the guide catheter to a point of occlusion in a connecting artery, e.g., the left or right hepatic artery.
When the distal end 318 of the inner catheter 314 is at the point of occlusion in the body cavity, the occluding device 10 is loaded at the proximal end 316 of the inner catheter 314 and is advanced through the inner catheter for deployment through the distal end 318. In this embodiment, a pushwire 326 is used to mechanically advance or push the occluding device 10 through the inner catheter 314. The size of the push wire used depends on the diameters of the inner catheter. As mentioned above, when the device 10 is deployed in the body vessel 14, the distal end 24 of the device 10 serves to hold the coil in place along the inner wall 16 of the body vessel 14. The proximal end 22 of the occluding device and the fibers 238 serve to occlude fluid flow by filling the lumen 12 of the body vessel 14.
In an alternative embodiment, an elongated releasing member made be used instead of a pushwire. The elongated releasing member is similar to the pushwire 326 in that it may be advanced through the inner catheter 314 to deploy the device 10 through the distal end 318. However, the elongated releasing member further includes a distal end configured for selectively engaging and/or disengaging with the device 10. Once the device 10 is deployed through the inner catheter 314, the elongated releasing member may be twisted or un-screwed to disengage the device 10 from the elongated releasing member, thus releasing the device 10 within the body vessel 14. Other suitable releasing devices known to those skilled in the art may also be used to advance and selectively deploy the occluding device 10 from the inner catheter 314.
As described earlier, depending upon the suture setup employed (
It is to be understood that the embolization kit 310 described above is merely one example of a kit that may be used to deploy the occluding device in a body vessel. Of course, other kits, assemblies, and systems may be used to deploy any embodiment of the occluding device without falling beyond the scope or spirit of the present.
The aforementioned as well as other embodiments are within the following claims.
This application claims the benefit of U.S. Provisional Application No. 61/428,420, filed on Dec. 30, 2011, entitled “DELIVERY OF AN EMBOLIZATION COIL WITH AN ATTACHER,” the entire contents of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
61428420 | Dec 2010 | US |